Hangzhou DAC Biotechnology Co., Ltd.
杭州多禧生物
Licensing announcements since 2025
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-05-21 | Whitehawk Therapeutics, Inc. | CPT113 linker-payload; additional ADC program options | Not disclosed | Not disclosed | Not disclosed | Discovery / preclinical |